News | January 16, 2026
Gabby Union-Wade fronts Bayer's new menopause drug, Lynkuet
The collaboration centers on the "Life Doesn't Stop for a Hot Flash" campaign
The collaboration centers on the "Life Doesn't Stop for a Hot Flash" campaign
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
The deal to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) underscores Bayer’s commitment to expanding in molecular imaging and advancing precision cardiology
The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts
Experts caution that realizing AI’s potential requires careful management and risk mitigation
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico
The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
The collaboration gives Axolabs access to Codexis’ innovative RNA manufacturing technology
The acquisition of AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) positions Bayer at the forefront of cardiac amyloidosis diagnostics
Subscribe To Our Newsletter & Stay Updated
